Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Cancer Epidemiol. 2013 Apr 23;37(4):518–522. doi: 10.1016/j.canep.2013.03.020

Table 2.

Genotype distributions under a dominant genetic model for 22 ESR2 single nucleotide polymorphisms (SNPs) and genotype-specific ERβ Allred score percentile cutpointsa (35th and 70th percentile cutpoints for cytoplasmic ERβ, 13th and 40th percentile cutpoints for nuclear ERβ, 30th and 70th percentile cutpoints for total ERβ).

Cytoplasmic ERβ Nuclear ERβ Total ERβ

SNP Genotype nb P35 P70 p-valuec P13 P40 p-valuec P30 P70 p-valuec
rs8021944 TT 118 5.5 7.7 0.081 5.5 7.8 0.029 5.5 7.8 0.053
TG+GG 15 7.0 8.0 7.9 8.0 7.5 8.0

rs968257 AA 44 5.5 7.8 0.576 5.0 7.9 0.439 5.5 7.9 0.500
AG+GG 77 5.8 7.8 6.5 8.0 6.2 7.9

rs1152589 AA 31 6.0 8.0 0.864 7.0 8.0 0.064 6.5 8.0 0.628
AT+TT 85 5.8 7.8 5.5 7.8 5.5 7.9

rs1255998 CC 100 6.0 8.0 0.259 5.5 8.0 0.185 6.3 8.0 0.214
CG+GG 33 5.0 7.3 6.5 7.6 5.5 7.5

rs8006145 CC 61 5.6 7.5 0.570 5.5 7.7 0.068 5.5 7.8 0.390
CA+AA 60 5.9 8.0 6.5 8.0 6.3 8.0

rs4986938 AluI GG 44 5.0 7.3 0.462 5.0 7.6 0.137 5.0 7.5 0.335
GA+AA 77 5.8 8.0 6.5 8.0 6.4 8.0

rs1256063 CC 108 5.6 8.0 0.756 6.0 8.0 0.271 5.9 8.0 0.500
CT+TT 13 6.5 7.3 0.0 7.5 4.8 7.5

rs1256061 CC 33 3.0 7.3 0.054 5.0 7.4 0.022 3.3 7.5 0.039
CA+AA 88 6.0 8.0 6.5 8.0 6.5 8.0

rs1952585 TT 96 6.0 8.0 0.130 5.5 8.0 0.173 6.4 8.0 0.127
TC+CC 25 5.0 7.0 6.5 7.5 5.5 7.4

rs17766755 GG 46 5.5 7.3 0.375 5.0 7.6 0.140 5.0 7.5 0.286
GA+AA 74 5.8 8.0 6.1 8.0 6.4 8.0

rs1256049 RsaI GG 112 6.0 8.0 0.421 5.8 8.0 0.584 5.5 8.0 0.340
GA+AA 8 4.0 7.0 6.5 7.6 6.0 7.5

rs8003490 GG 110 6.0 8.0 0.054 5.5 8.0 0.119 6.6 8.0 0.065
GA+AA 23 4.0 7.0 6.1 7.5 5.0 7.5

rs12435284 CC 109 5.5 7.7 0.073 5.8 7.8 0.087 5.5 7.9 0.055
CT+TT 12 7.0 8.0 7.9 8.0 7.5 8.0

rs1256036 AA 33 5.0 8.0 0.774 6.5 8.0 0.434 5.5 8.0 0.969
AG+GG 88 6.0 7.8 5.5 8.0 6.2 7.9

rs1887994 GG 102 5.6 7.8 0.584 5.8 8.0 0.981 5.5 7.9 0.667
GT+TT 19 6.0 8.0 6.5 7.8 6.5 8.0

rs3020450 GG 52 6.0 7.8 0.886 5.5 7.9 0.727 6.0 7.9 0.842
GA+AA 69 5.8 8.0 6.1 8.0 5.5 8.0

rs3020449 TT 38 4.0 7.4 0.156 5.0 7.6 0.114 4.0 7.5 0.117
TC+CC 82 6.0 8.0 6.5 8.0 6.2 8.0

rs10137185 CC 106 5.5 7.8 0.080 5.5 7.8 0.149 5.0 7.9 0.065
CT+TT 15 7.0 8.0 7.6 8.0 7.4 8.0

rs3020443 AA 66 5.6 7.5 0.433 5.5 7.8 0.109 5.9 7.8 0.322
AC+CC 54 6.0 8.0 6.5 8.0 6.5 8.0

rs1256120 TT 100 5.3 7.8 0.567 5.6 8.0 0.843 5.3 7.9 0.561
TC+CC 19 6.8 7.9 6.5 7.9 7.0 7.9

rs10146204 GG 42 4.0 7.0 0.051 5.0 7.5 0.025 4.0 7.5 0.029
GA+AA 79 6.0 8.0 6.5 8.0 6.2 8.0

rs1256108 TT 30 3.0 7.4 0.119 5.0 7.6 0.211 3.8 7.6 0.103
TC+CC 101 6.0 8.0 6.5 8.0 6.6 8.0
a

Percentile cutpoints distinguish no/low (Allred <6) from intermediate (Allred 6 to 7) and intermediate from maximal (Allred 8) ERβ expression in the entire (n=135) subject set.

b

ESR2 genotypes evaluable for n=133 subjects at four SNPs (rs8021944, rs1255998, rs8003490, and rs1256108) measured on one Sequenom multiplex and evaluable for n=121 subjects at 18 other SNPs measured on a separated multiplex.

c

Statistical significance (Wilcoxon test) of genotype-specific differences in the Allred scores.